Whole exome and transcriptome analysis of UV-exposed epidermis and carcinoma in situ reveals early drivers of carcinogenesis.

Squamous cell carcinoma in situ (SCCIS) is a prevalent precancerous lesion that can progress to cutaneous squamous cell carcinoma (cSCC). Although SCC…

ASCO Statement Recommends That Skin Cancer Prevention Focus on Four Core Areas

Reducing the risk for skin cancer requires targeted strategies in four areas, a policy statement from the American Society of Clinical Oncology reports. The statement, published online in May and in the August print edition of JCO Oncology Practice, makes recommendations on the prevention of the three most prominent skin cancers, melanoma, basal cell carcinoma, and squamous cell carcinoma, across…

FDA Updates Hydrochlorothiazide Label for Nonmelanoma Skin Cancer

Hydrochlorothiazide is associated with an increased risk of nonmelanoma skin cancer, according to updates to the medication’s label.

Nivo + ipi in unresectable stage III/IV melanoma

Michael Postow, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, USA, talks through data from a phase II…

Sun Safety | Skin Cancer | CDC

Ways to protect your skin from the sun.

JNCCN 360 – Non-Melanoma Skin Cancers – Is Hydrochlorothiazide Linked to Increased Risk for Skin Cancer?

By: Kelly M. Hennessey, PhD Posted: Friday, August 14, 2020 The hypertension medication hydrochlorothiazide is known to have photosensitizing properties, and many agencies have suggested its use may be linked to an increased risk for skin cancer. Helga Zoega, PhD, of the University of New South Wales (UNSW)…

Statin Use May Protect Against Squamous Cell Carcinoma

The use of statin blood thinners may be protective against adverse outcomes in patients with head and neck squamous cell carcinoma (HNSCC), especially individuals with human papillomavirus (HPV), according to findings from a large, prospective study presented June 22 at the American Association for Cancer Research (AACR) Virtual Meeting II (Abstract 3391).

Anyone Can Get Skin Cancer

No matter if your skin is light, dark, or somewhere in between, everyone is at risk for skin cancer. Learn what skin cancer looks like, how to find it early, and how to lower the chance of skin cancer.

Moletest offers skin cancer screening test to primary care professionals

The medical technology company aims to reduce unnecessary dermatology referrals to secondary care.

Article – JDDonline – Journal of Drugs in Dermatology

Why write another review about sunscreens? The sunscreen market is complex, competitive and confusing to consumers and healthcare providers alike. Because dermatologic patients look to their providers for expert advice about sun protection, it behooves us to offer accurate information and practical guidelines for obtaining the best products, especially because many of the private label offerings…